Arthritis-drug ads won't name product

Article Abstract:

Monsanto Co.'s G.D. Searle pharmaceuticals unit is launching a television ad campaign for its hot-selling new arthritis drug Celebrex that will not name the product. This is due to regulations that require the company to mention any potential side effects if the product is actually mentioned. By not naming the drug, Searle is able to sidestep having to inform viewers about the potential for existing arthritis-pain drugs to cause potentially fatal bleeding ulcers in about one percent of chronic users each year. Celebrex became the fastest-selling pharmaceutical product since companies began monitoring this data, but sales have fallen off recently after news reports about some ulcers occurring in a handful of patients taking the drug. The campaign, created by the Leo Burnett agency, will focus on arthritis pain and provide an 800 number that viewers can call to receive information. Another campaign that will mention Celebrex specifically is planned for later this year.

Advertising agencies, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Campaign Launched, Legal/Government Regulation, Antiarthritic Analgesic Preps, Pharmaceutical industry, Finance, Advertising, Chemical industry, MTC, Leo Burnett Company Inc., G.D. Searle and Co., Celebrex (Medication), Antiarthritic agents

---

Cargill searches for a corporate identity

Article Abstract:

Cargill Inc. hired Martin/Williams Advertising agency to work on its first big corporate identity campaign. Martin/Williams plans to launch Cargill's television and print ads early next year across North America. Cargill may be the largest company Americans know the least about, even though its businesses handle much of what ends up on their plates each day. Based on the North American campaign, Cargill will decide whether to take the image campaign international where it has around 40% of its facilities.

Use of services, Contracts & orders received, Chemicals & Allied Products, Chemical Manufacturing, Account Activity, Chemicals, Cargill Inc., Martin-Williams Inc.

---

Monsanto brings 'Genetic' ads to Europe

Article Abstract:

Monsanto is spending about $5 million on advertisements in British and French newspapers to promote genetic engineering for crops. The purpose of the campaign is to persuade leary Europeans that genetic engineering for crops is beneficial. Supermarket executives are happy that Monsanto is taking some of the heat from worried consumers. Antibiotech activists, including the Prince of Whales, are upset by the ads. Some of Monsanto's contemporaries are worried the ads will grate on the suspicious public.

Comment:

Spends $5 million to promote genetic engineering for crops

Europe, Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences

Similar abstracts:

• Abstracts: British Air's new no-frills carrier, Go, to battle its discount rivals. AMR-British air linkup just keeps circling, circling
• Abstracts: Intel files suit against Intergraph, launches counterattack against FTC. Intel appeals judge's ruling on Intergraph
• Abstracts: FTC orders Novartis ads to correct claim. NHTSA creates a class for electric vehicles
• Abstracts: U.S. report on Net commerce set for release; key recommendations stress self-regulation
• Abstracts: NextWave sues FCC over licenses won in bidding. Sales of Apple's iMac Blossom, retailers say. Cisco, Pirelli explore pact for fiber gear

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.